PCOS Is Now PMOS: What the Name Change Actually Means
If you have been living with a PCOS diagnosis, you may have spent years trying to explain a condition whose name never quite captured what was actually happening in your body. Polycystic ovary syndrome. Cysts. Ovaries. Syndrome. None of it quite added up to the fatigue, the insulin resistance, the mood shifts, the irregular cycles, the skin changes, or the feeling that something much bigger was going on.
You were right. And on May 12, 2026, the medical community officially agreed.
PCOS has been renamed. The new name is polyendocrine metabolic ovarian syndrome, abbreviated as PMOS. This change was published in The Lancet following an unprecedented global consensus process involving 14,360 survey respondents, 56 international organizations, and workshops held across world regions. It is the most significant renaming in women's hormonal health in decades.
At Bonita, this rename is not a surprise. It is a validation. We have always approached hormonal health through an integrative lens, treating the full endocrine and metabolic picture rather than isolating one organ or one symptom. The women who have sat across from me in consultation have known for years that PCOS was bigger than its name. Now the medical community has caught up.
I want to explain what this means, why it matters, and what it changes about how we approach your care here at Bonita.
Why Was PCOS Renamed?
The term polycystic ovary syndrome implied that pathological ovarian cysts were a defining feature of the condition. They are not. Up to 70 percent of people with PCOS have never been diagnosed, in part because the name itself was misleading.
The word polycystic led many women, and many clinicians, to believe that cysts on the ovaries were the central problem. But research has long shown that the condition is driven by something far more complex: a multisystem dysfunction involving the endocrine system, the metabolic system, and the ovaries together.
Women with PCOS experience elevated androgens, insulin resistance, disrupted ovulation, and a cascade of metabolic consequences that can include weight gain, type 2 diabetes risk, cardiovascular changes, mood dysregulation, sleep disruption, acne, hair thinning, and infertility. None of that is captured in the word polycystic.
The new name, polyendocrine metabolic ovarian syndrome, does a much better job. Polyendocrine acknowledges that multiple hormonal systems are involved, not just one. Metabolic acknowledges the insulin and weight components that are central to so many women's experience of this condition. Ovarian acknowledges the ovarian dysfunction without implying cysts that do not exist.
This is not a cosmetic change. It is a correction.
What Does PMOS Actually Look Like?
PMOS affects one in eight women globally and is one of the most underdiagnosed hormonal conditions in Canada. It does not disappear at menopause, and it often overlaps significantly with perimenopause.
One of the things I see most often in my practice is women who have been struggling with a cluster of symptoms for years, sometimes decades, without a clear answer. They have been told their bloodwork is normal. They have been told their symptoms are stress. They have been told to lose weight, exercise more, or come back when things get worse.
PMOS symptoms vary widely between women, which is part of why it is so frequently missed. They can include:
Irregular or absent periods
Difficulty losing weight, particularly around the midsection
Insulin resistance or elevated fasting blood sugar
Acne along the jaw, chin, or back
Hair thinning on the scalp
Excess facial or body hair
Fatigue, brain fog, and mood changes
Low libido and sleep disruption
Fertility challenges
Not every woman with PMOS will have all of these. Some women present primarily with metabolic features. Others present primarily with reproductive or dermatological ones. The range is part of what made the old name so inadequate, and part of why so many women went undiagnosed for so long.
What Has Actually Changed With the New Name?
The condition itself has not changed. What has changed is the framework: the name now opens the door to better diagnosis, more appropriate research funding, and more comprehensive clinical care.
I want to be clear about something: if you have a PCOS diagnosis, that diagnosis is still valid. The condition is the same condition. Your symptoms are the same symptoms. What changes is what we call it, and more importantly, how the medical system frames it going forward.
The global implementation plan includes updating the International Guidelines used in 195 countries, integrating the new terminology into ICD disease classification codes, and updating medical education and electronic health records. This is a 3-year transition, which means you will likely see both PCOS and PMOS used for some time.
For women in Canada, the practical implication is that clinicians who stay current will begin framing this condition as the metabolic and endocrine disorder it actually is, rather than a reproductive or gynaecological one. That shift in framing changes everything about how it is assessed and treated.
Why Does This Matter for Perimenopause?
PMOS does not stop at menopause. Women with PMOS who enter perimenopause often experience a compounding of hormonal disruption, as declining estrogen interacts with existing insulin resistance and androgen excess.
This is something I care deeply about because it is something I see regularly. A woman comes in with worsening symptoms in her 40s. She has been managing PCOS for years with some success, and now everything feels harder. The weight gain is accelerating. The mood changes are more pronounced. The sleep is worse.
What is often happening is that the hormonal shifts of perimenopause are layering on top of an already disrupted endocrine environment. The two conditions interact in ways that make both harder to manage when treated in isolation.
At Bonita, I assess hormonal health as a whole picture. When someone comes in with PMOS and perimenopausal symptoms, I am not treating two separate conditions. I am looking at one hormonal system that is being disrupted from multiple directions, and building a plan that addresses all of it.
How Does Bonita Assess and Treat PMOS?
A thorough PMOS assessment looks beyond a single blood test. It evaluates androgens, insulin, cortisol, thyroid, estrogen, progesterone, and metabolic markers together to build a complete picture of your hormonal health.
This is how we have always worked at Bonita. Long before the rename, our approach was to assess the full hormonal and metabolic picture, not just tick a diagnostic box. If you have been told your bloodwork is normal and yet your symptoms persist, a more targeted assessment will often tell a very different story.
At Bonita, my assessment approach for women who may have PMOS includes a detailed consultation covering symptoms, cycle history, metabolic health, skin changes, and family history, followed by targeted lab work. From there, I build a plan that may include:
Hormone optimization to address the perimenopausal layer if relevant
Metabolic Balance, our 12-week personalized nutrition program built from your individual blood values, which is particularly well suited to the metabolic component of PMOS
Medical-grade skincare and aesthetic support for skin changes driven by androgen excess
Referral to pelvic floor physiotherapy with Kristen Parise, PT for any pelvic or intimate health concerns
No referral is needed. Virtual consultations are available across Ontario, which means you do not need to be local to St. Jacobs to access this care.
Not Sure If This Applies to You?
If you have a PCOS diagnosis, this post is directly relevant to you. But if you have never been diagnosed and some of what I have described resonates, it is worth paying attention to that.
PMOS affects one in eight women and up to 70 percent go undiagnosed. If you have been managing a cluster of symptoms without clear answers, a hormonal assessment at Bonita is a good place to start. You do not need to arrive with a diagnosis. You just need to arrive with your symptoms and a willingness to get a real picture of what is going on.
At Bonita, we have been treating the condition that the world now calls PMOS for years. The name has finally caught up to the care. If any of what I have described resonates, I invite you to book a virtual consultation with me directly. We will look at your full hormonal picture together and figure out what is actually going on.

